{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T11:19:19Z","timestamp":1785842359708,"version":"3.56.0"},"reference-count":76,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jogc.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Obstetrics and Gynaecology Canada"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.jogc.2018.07.004","type":"journal-article","created":{"date-parts":[[2018,12,20]],"date-time":"2018-12-20T23:08:21Z","timestamp":1545347301000},"page":"89-101","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["No. 370-Management of Squamous Cell Cancer of the Vulva"],"prefix":"10.1016","volume":"41","author":[{"given":"Julie Ann","family":"Francis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lua","family":"Eiriksson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Dean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Sebastianelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris","family":"Bahoric","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon","family":"Salvador","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jogc.2018.07.004_bib0001","unstructured":"National Cancer Institute. Cancer Stat Facts: Vulvar Cancer. Bethesda, MD: National Cancer Institute. Available at: https:\/\/seer.cancer.gov\/statfacts\/html\/vulva.html. Accessed on August 3, 2018."},{"key":"10.1016\/j.jogc.2018.07.004_bib0002","series-title":"Canadian Cancer Statistics 2015","year":"2015"},{"key":"10.1016\/j.jogc.2018.07.004_bib0003","series-title":"Cancer: principles & practice of oncology","first-page":"1311","article-title":"Cancer of the cervix, vagina and vulva","author":"Eifel","year":"2011"},{"key":"10.1016\/j.jogc.2018.07.004_bib0004","first-page":"692","article-title":"Cancer of the vulva: an analysis of 155 cases","volume":"79","author":"Taussig","year":"1960","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jogc.2018.07.004_bib0005","first-page":"287","article-title":"New gynecologic cancer staging","volume":"75","author":"Creasman","year":"1990","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jogc.2018.07.004_bib0006","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1471-0528.1996.tb09764.x","article-title":"Cervical and vulva cancer: changes in FIGO definitions of staging","volume":"103","author":"Shepherd","year":"1996","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.jogc.2018.07.004_bib0007","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ijgo.2009.02.012","article-title":"Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium","volume":"105","author":"Pecorelli","year":"2009","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.jogc.2018.07.004_bib0008","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1097\/IGC.0b013e318241d994","article-title":"Validation of the 2009 FIGO staging system for for carcinoma of the vulva","volume":"22","author":"Tan","year":"2012","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.jogc.2018.07.004_bib0009","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/0002-9378(91)90573-A","article-title":"Assessment of current International Federation of Gynecology and Obstetrics staging of vulvar carcinoma relative to prognostic factors for survival. (Gynecologic Oncology Group Study)","volume":"164","author":"Homesley","year":"1991","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jogc.2018.07.004_bib0010","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/LGT.0b013e3182472947","article-title":"Prevalence of human papillomavirus types in invasive vulvar cancers and vulvar intraepithelial neoplasia 3 in the United States before vaccine introduction","volume":"16","author":"Gargano","year":"2012","journal-title":"J Low Genit Tract Dis"},{"key":"10.1016\/j.jogc.2018.07.004_bib0011","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1093\/infdis\/jis590","article-title":"Fall in human papillomavirus prevalence following a national vaccination program","volume":"206","author":"Tabrizi","year":"2012","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jogc.2018.07.004_bib0012","doi-asserted-by":"crossref","first-page":"527","DOI":"10.4103\/0378-6323.44333","article-title":"Improving diagnostic yield of punch biopsies of the skin","volume":"74","author":"Khopkar","year":"2008","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.jogc.2018.07.004_bib0013","doi-asserted-by":"crossref","first-page":"e178","DOI":"10.1097\/AOG.0000000000001713","article-title":"Committee opinion no. 675: management of vulvar intraepithelial neoplasia","volume":"128","year":"2016","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jogc.2018.07.004_bib0014","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1056\/NEJMoa061760","article-title":"Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases","volume":"356","author":"Garland","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jogc.2018.07.004_bib0015","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1056\/NEJMoa061741","article-title":"Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions","volume":"356","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jogc.2018.07.004_bib0016","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1016\/S0140-6736(07)60946-5","article-title":"Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial","volume":"369","author":"Paavonen","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.jogc.2018.07.004_bib0017","doi-asserted-by":"crossref","first-page":"4795","DOI":"10.1016\/j.vaccine.2008.07.002","article-title":"Rationale and design of a community-based double-blind randomized clinical trial of an HPV 16 and 18 vaccine in Guanacaste, Costa Rica","volume":"26","author":"Herrero","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.jogc.2018.07.004_bib0018","series-title":"Contemporary clinical questions on HPV-related diseases and vaccination","year":"2015"},{"key":"10.1016\/j.jogc.2018.07.004_bib0019","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/00001703-199901000-00011","article-title":"Radical resection of vulvar malignancies: a paradigm shift in surgical approaches","volume":"11","author":"Hacker","year":"1999","journal-title":"Curr Opin Obstet Gynecol"},{"key":"10.1016\/j.jogc.2018.07.004_bib0020","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/S1470-2045(10)70104-2","article-title":"Size of sentinel-node metastasis and chances of non-sentinel-node involvement and survival in early stage vulvar cancer: results from GROINSS-V, a multicentre observational study","volume":"11","author":"Oonk","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jogc.2018.07.004_bib0021","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ygyno.2016.01.013","article-title":"Repeat sentinel lymph node procedure in patients with recurrent vulvar squamous cell carcinoma is feasible","volume":"140","author":"van Doorn","year":"2016","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jogc.2018.07.004_bib0022","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1245\/s10434-012-2735-2","article-title":"Secondary sentinel node biopsy after previous excision of the primary tumor in squamous cell carcinoma of the vulva","volume":"20","author":"Woelber","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jogc.2018.07.004_bib0023","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ygyno.2012.11.034","article-title":"Is bilateral lymphadenectomy for midline squamous carcinoma of the vulva always necessary? An analysis from Gynecologic Oncology Group (GOG) 173","volume":"128","author":"Coleman","year":"2013","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jogc.2018.07.004_bib0024","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1245\/s10434-016-5114-6","article-title":"The risk of contralateral non-sentinel metastasis in patients with primary vulvar cancer and unilaterally positive sentinel node","volume":"23","author":"Woelber","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jogc.2018.07.004_bib0025","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ygyno.2015.02.014","article-title":"Sentinel lymph node biopsy in vulvar cancer: systematic review, meta-analysis and guideline recommendations","volume":"137","author":"Covens","year":"2015","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jogc.2018.07.004_bib0026","doi-asserted-by":"crossref","first-page":"3786","DOI":"10.1200\/JCO.2011.41.2528","article-title":"Lymphatic mapping and sentinel lymph node biopsy in women with squamous cell carcinoma of the vulva: a Gynecologic Oncology Group study","volume":"30","author":"Levenback","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jogc.2018.07.004_bib0027","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/00000421-198704000-00055","article-title":"Combined therapy as an alternative to exenteration for locally advanced vulvovaginal cancer","volume":"10","author":"Boronow","year":"1987","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.jogc.2018.07.004_bib0028","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ygyno.2010.11.044","article-title":"Pelvic exenteration in the age of modern chemoradiation","volume":"121","author":"McLean","year":"2011","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jogc.2018.07.004_bib0029","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/0090-8258(90)90156-F","article-title":"Effective chemotherapy consisting of bleomycin, vincristine, mitomycin C. and cisplatin (BOMP) for a patient with inoperable vulvar cancer","volume":"36","author":"Shimizu","year":"1990","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jogc.2018.07.004_bib0030","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1006\/gyno.1993.1163","article-title":"Cisplatin (P), bleomycin (B) and methotrexate (M) preoperative chemotherapy in locally advanced vulvar carcinoma","volume":"50","author":"Benedetti-Panici","year":"1993","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jogc.2018.07.004_bib0031","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/0090-8258(90)90367-T","article-title":"Bleomycin, methotrexate and CCNU in advanced inoperable squamous cell carcinoma of the vulva: a phase II study of the EORTC Gynaecological Cancer Cooperative Group (GCCG)","volume":"37","author":"Durrant","year":"1990","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.jogc.2018.07.004_bib0032","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003752.pub2","article-title":"Neoadjuvant chemoradiation for advanced primary vulvar cancer","author":"Van Doorn","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jogc.2018.07.004_bib0033","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0360-3016(98)00193-X","article-title":"Preoperative chemo-radiation for advanced vulvar cancer: a phase II study of the Gynecologic Oncology Group","volume":"42","author":"Moore","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jogc.2018.07.004_bib0034","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1097\/IGC.0000000000000938","article-title":"Primary versus preoperative radiation for locally advanced vulvar cancer","volume":"27","author":"Natesan","year":"2017","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.jogc.2018.07.004_bib0035","first-page":"733","article-title":"Radiation therapy versus pelvic node resection for carcinoma of the vulva with positive groin nodes","volume":"68","author":"Homesley","year":"1986","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jogc.2018.07.004_bib0036","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1097\/AOG.0b013e3181b12f99","article-title":"Radiation therapy compared with pelvic node resection of node positive vulvar cancer: a randomized controlled trial","volume":"114","author":"Kunos","year":"2009","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jogc.2018.07.004_bib0037","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/0360-3016(92)90699-I","article-title":"Groin dissection versus groin radiation in carcinoma of the vulva: a Gynecologic Oncology Group study","volume":"24","author":"Stehman","year":"1992","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jogc.2018.07.004_bib0038","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/0360-3016(93)90476-C","article-title":"Femoral vessel depth and the implications for groin node radiation","volume":"27","author":"Koh","year":"1993","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jogc.2018.07.004_bib0039","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/0360-3016(93)90475-B","article-title":"Inguinofemoral radiation of N0,N1 vulvar cancer may be equivalent to lymphadenectomy if proper radiation technique is used","volume":"27","author":"Petereit","year":"1993","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jogc.2018.07.004_bib0040","doi-asserted-by":"crossref","first-page":"422","DOI":"10.5301\/tj.5000529","article-title":"The role of radiation therapy in vulvar cancer: review of the current literature","volume":"103","author":"Sciacero","year":"2017","journal-title":"Tumori"},{"key":"10.1016\/j.jogc.2018.07.004_bib0041","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.ijrobp.2005.11.007","article-title":"Intensity-modulated radiotherapy for the treatment of vulvar carcinoma: a comparative dosimetric study with early clinical outcome","volume":"64","author":"Beriwal","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jogc.2018.07.004_bib0042","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.ygyno.2007.10.026","article-title":"Preoperative intensity-modulated radiotherapy and chemotherapy for locally advanced vulvar carcinoma","volume":"109","author":"Beriwal","year":"2008","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jogc.2018.07.004_bib0043","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s13014-016-0628-4","article-title":"Genital invasion or perigenital spread may pose a risk of marginal misses for intensity modulated radiotherapy (IMRT) in anal cancer","volume":"11","author":"Koeck","year":"2016","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.jogc.2018.07.004_bib0044","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/COC.0000000000000322","article-title":"Vulvar recurrences after intensity-modulated radiation therapy for squamous cell carcinoma of the anus","volume":"41","author":"Bagshaw","year":"2018","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.jogc.2018.07.004_bib0045","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0090-8258(90)90064-R","article-title":"Surgical-pathologic variables predictive of local recurrence in squamous cell carcinoma of the vulva","volume":"38","author":"Heaps","year":"1990","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jogc.2018.07.004_bib0046","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ejca.2016.07.006","article-title":"Tumour-free margins in vulvar squamous cell carcinoma: does distance really matter?","volume":"65","author":"Nooij","year":"2016","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jogc.2018.07.004_bib0047","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ejca.2016.09.038","article-title":"Role of tumour-free margin distance for loco-regional control in vulvar cancer: a subset analysis of the Arbeitsgemeinschaft Gynakologische Onkologie CaRE-1 multicenter study","volume":"69","author":"Woelber","year":"2016","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jogc.2018.07.004_bib0048","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s00432-015-2060-9","article-title":"Adjuvant radiotherapy for vulvar cancer with close or positive surgical margins","volume":"142","author":"Ignatov","year":"2016","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.jogc.2018.07.004_bib0049","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/COC.0b013e3181cae6a1","article-title":"The role of chemo-radiotherapy in the management of locally advanced carcinoma of the vulva: single institutional experience and review of literature","volume":"34","author":"Tans","year":"2011","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.jogc.2018.07.004_bib0050","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.ygyno.2015.03.056","article-title":"Impact of adjuvant chemotherapy with radiation for node-positive vulvar cancer: a National Cancer Database (NCDB) analysis","volume":"137","author":"Gill","year":"2015","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jogc.2018.07.004_bib0051","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ygyno.2017.03.499","article-title":"Surgical management vs primary radiotherapy for vulvar cancer [abstract]","volume":"145","author":"Sullivan","year":"2017","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jogc.2018.07.004_bib0052","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.ygyno.2007.11.010","article-title":"Comparison of outcome measures in patients with advanced squamous cell carcinoma of the vulva treated with surgery or primary chemoradiation","volume":"108","author":"Landrum","year":"2008","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jogc.2018.07.004_bib0053","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0360-3016(98)00193-X","article-title":"Preoperative chemoradiation for advanced vulvar cancer: a phase II study of the Gynecologic Oncology Group","volume":"42","author":"Moore","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jogc.2018.07.004_bib0054","doi-asserted-by":"crossref","first-page":"198","DOI":"10.3857\/roj.2015.33.3.198","article-title":"Treatment outcomes of curative radiotherapy in patients with vulvar cancer: results of the retrospective KROG 1203 study","volume":"33","author":"Kim","year":"2015","journal-title":"Radiat Oncol J"},{"key":"10.1016\/j.jogc.2018.07.004_bib0055","series-title":"Principles and practice of gynecologic oncology","author":"Barakat","year":"2013"},{"key":"10.1016\/j.jogc.2018.07.004_bib0056","series-title":"Berek and Hacker's gynecologic oncology","author":"Berek","year":"2014"},{"key":"10.1016\/j.jogc.2018.07.004_bib0057","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/IGC.0b013e3181c93adc","article-title":"Neoadjuvant chemotherapy in advanced vulvar cancer","volume":"20","author":"Domingues","year":"2010","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.jogc.2018.07.004_bib0058","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3802\/jgo.2014.25.1.22","article-title":"Role of paclitaxel and cisplatin as the neoadjuvant treatment for locally advanced squamous cell carcinoma of the vulva","volume":"25","author":"Raspagliesi","year":"2014","journal-title":"J Gynecol Oncol"},{"key":"10.1016\/j.jogc.2018.07.004_bib0059","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ygyno.2005.06.068","article-title":"Neoadjuvant chemotherapy in vulvar cancer: avoiding primary exenteration","volume":"100","author":"Geisler","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jogc.2018.07.004_bib0060","doi-asserted-by":"crossref","first-page":"1258\u201463","DOI":"10.1097\/IGC.0b013e318263ef55","article-title":"Tailoring the treatment of locally advanced squamous cell carcinoma of the vulva: neoadjuvant chemotherapy followed by radical surgery: results from a multicenter study","volume":"22","author":"Aragona","year":"2012","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.jogc.2018.07.004_bib0061","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1097\/IGC.0b013e31824b4058","article-title":"Weekly paclitaxel\/carboplatin in the treatment of locally advanced, recurrent, or metastatic vulvar cancer","volume":"22","author":"Han","year":"2012","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.jogc.2018.07.004_bib0062","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1093\/annonc\/mdp043","article-title":"Phase II study on paclitaxel in patients with recurrent, metastatic or locally advanced vulvar cancer not amenable to surgery or radiotherapy: a study of the EORTC-GCG (European Organisation for Research and Treatment of Cancer\u2013Gynaecological Cancer Group)","volume":"20","author":"Witteveen","year":"2009","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jogc.2018.07.004_bib0063","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ejogrb.2017.03.030","article-title":"Neoadjuvant and definitive chemotherapy or chemoradiation for stage III and IV vulvar cancer: a pooled reanalysis","volume":"212","author":"Forner","year":"2017","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.jogc.2018.07.004_bib0064","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1111\/bjd.14188","article-title":"A case of recurrent squamous cell carcinoma of the vulva successfully treated by combination therapy with cetuximab and paclitaxel","volume":"174","author":"Matsuzawa","year":"2016","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jogc.2018.07.004_bib0065","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1111\/j.1525-1438.2007.01145.x","article-title":"Recurrent metastatic vulvar carcinoma treated with cisplatin plus cetuximab","volume":"18","author":"Richard","year":"2008","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.jogc.2018.07.004_bib0066","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ygyno.2012.06.028","article-title":"Phase II trial of erlotinib in women with squamous cell carcinoma of the vulva","volume":"127","author":"Horowitz","year":"2012","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jogc.2018.07.004_bib0067","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/1097-0142(20000701)89:1<116::AID-CNCR16>3.0.CO;2-4","article-title":"Patterns of recurrence in patients with squamous cell carcinoma of the vulva: a multicentre CTF study","volume":"89","author":"Maggino","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.jogc.2018.07.004_bib0068","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1002\/cncr.11837","article-title":"The value of routine follow-up in patients treated for carcinoma of the vulva","volume":"98","author":"Oonk","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.jogc.2018.07.004_bib0069","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.critrevonc.2011.09.003","article-title":"Clinico-pathological and biological prognostic variables in squamous cell carcinoma of the vulva","volume":"83","author":"Gadducci","year":"2012","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.jogc.2018.07.004_bib0070","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S1521-6934(03)00050-6","article-title":"Local and regional recurrence of vulval cancer: management dilemmas","volume":"17","author":"Coulter","year":"2003","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.jogc.2018.07.004_bib0071","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.critrevonc.2016.07.007","article-title":"Risk factors and treatment for recurrent vulvar squamous cell carcinoma","volume":"106","author":"Nooij","year":"2016","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.jogc.2018.07.004_bib0072","article-title":"Long-term survival and disease recurrence in patients with primary squamous cell carcinoma of the vulva","volume":"97","author":"Gonzalez","year":"2005","journal-title":"Gynecol. Oncol"},{"key":"10.1016\/j.jogc.2018.07.004_bib0073","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ygyno.2016.05.019","article-title":"Prognostic importance of human papillomavirus (HPV) and p16 positivity in squamous cell carcinoma treated with radiotherapy","volume":"142","author":"Lee","year":"2016","journal-title":"Gynecol Oncol"},{"issue":"Suppl 1","key":"10.1016\/j.jogc.2018.07.004_bib0074","first-page":"S7","article-title":"Carcinoma of the vulva. FIGO 26th annual report on the results of treatment in gynecological cancer","volume":"95","author":"Beller","year":"2006","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.jogc.2018.07.004_bib0075","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1097\/IGC.0000000000000637","article-title":"Should groin recurrence still be considered as a palliative situation in vulvar cancer patients? A brief report","volume":"26","author":"Frey","year":"2016","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.jogc.2018.07.004_bib0076","first-page":"302","article-title":"Groin recurrence in carcinoma of the vulva: management and outcome","volume":"19","author":"Cormio","year":"2010","journal-title":"Eur J Cancer Care (Engl)"}],"container-title":["Journal of Obstetrics and Gynaecology Canada"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S170121631830570X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S170121631830570X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T15:33:01Z","timestamp":1761665581000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S170121631830570X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":76,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S170121631830570X"],"URL":"https:\/\/doi.org\/10.1016\/j.jogc.2018.07.004","relation":{},"ISSN":["1701-2163"],"issn-type":[{"value":"1701-2163","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"No. 370-Management of Squamous Cell Cancer of the Vulva","name":"articletitle","label":"Article Title"},{"value":"Journal of Obstetrics and Gynaecology Canada","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jogc.2018.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Society of Obstetricians and Gynaecologists of Canada. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}